Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape

Abstract Morquio B disease (MBD) is an ultra-rare lysosomal storage disease, which represents the relatively mild form of GLB1-associated disorders. In this article, we present the unique case of “pure” MBD associated with an insertion of the mobile genetic element from the class of retrotransposons...

Full description

Bibliographic Details
Main Authors: Igor Bychkov, Antonina Kuznetsova, Galina Baydakova, Leonid Gorobets, Vladimir Kenis, Alena Dimitrieva, Alexandra Filatova, Vyacheslav Tabakov, Mikhail Skoblov, Ekaterina Zakharova
Format: Article
Language:English
Published: Nature Portfolio 2022-07-01
Series:npj Genomic Medicine
Online Access:https://doi.org/10.1038/s41525-022-00315-y
_version_ 1818162618007814144
author Igor Bychkov
Antonina Kuznetsova
Galina Baydakova
Leonid Gorobets
Vladimir Kenis
Alena Dimitrieva
Alexandra Filatova
Vyacheslav Tabakov
Mikhail Skoblov
Ekaterina Zakharova
author_facet Igor Bychkov
Antonina Kuznetsova
Galina Baydakova
Leonid Gorobets
Vladimir Kenis
Alena Dimitrieva
Alexandra Filatova
Vyacheslav Tabakov
Mikhail Skoblov
Ekaterina Zakharova
author_sort Igor Bychkov
collection DOAJ
description Abstract Morquio B disease (MBD) is an ultra-rare lysosomal storage disease, which represents the relatively mild form of GLB1-associated disorders. In this article, we present the unique case of “pure” MBD associated with an insertion of the mobile genetic element from the class of retrotransposons. Using whole-genome sequencing (WGS), we identified an integration of the processed pseudogene NPM1 deep in the intron 5 of GLB1. The patient’s mRNA analysis and the detailed functional analysis revealed the underlying molecular genetic mechanism of pathogenesis, which is an alteration of the GLB1 normal splicing. By co-expression of minigenes and antisense splice-modulating oligonucleotides (ASMOs), we demonstrated that pseudogene-derived splicing regulatory motifs contributed to an activation of the cryptic exon located 36 bp upstream of the integration site. Blocking the cryptic exon with ASMOs incorporated in the modified U7 small nuclear RNA (modU7snRNA) almost completely restored the wild-type splicing in the model cell line, that could be further extended toward the personalized genetic therapy. To our knowledge, this is the second reported case of the processed pseudogene insertion for monogenic disorders. Our data emphasizes the unique role of WGS in identification of such rare and probably underrepresented in literature types of disease-associated genetic variants.
first_indexed 2024-12-11T16:36:31Z
format Article
id doaj.art-e21593aacde74b53b521f3ae1e5957fb
institution Directory Open Access Journal
issn 2056-7944
language English
last_indexed 2024-12-11T16:36:31Z
publishDate 2022-07-01
publisher Nature Portfolio
record_format Article
series npj Genomic Medicine
spelling doaj.art-e21593aacde74b53b521f3ae1e5957fb2022-12-22T00:58:27ZengNature Portfolionpj Genomic Medicine2056-79442022-07-01711610.1038/s41525-022-00315-yProcessed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscapeIgor Bychkov0Antonina Kuznetsova1Galina Baydakova2Leonid Gorobets3Vladimir Kenis4Alena Dimitrieva5Alexandra Filatova6Vyacheslav Tabakov7Mikhail Skoblov8Ekaterina Zakharova9Research Centre for Medical GeneticsResearch Centre for Medical GeneticsResearch Centre for Medical GeneticsClinical and Diagnostic Center “Zdorovoe detstvo”H. Turner National Medical Research Centre for Children’s Orthopedics and Trauma SurgeryH. Turner National Medical Research Centre for Children’s Orthopedics and Trauma SurgeryResearch Centre for Medical GeneticsResearch Centre for Medical GeneticsResearch Centre for Medical GeneticsResearch Centre for Medical GeneticsAbstract Morquio B disease (MBD) is an ultra-rare lysosomal storage disease, which represents the relatively mild form of GLB1-associated disorders. In this article, we present the unique case of “pure” MBD associated with an insertion of the mobile genetic element from the class of retrotransposons. Using whole-genome sequencing (WGS), we identified an integration of the processed pseudogene NPM1 deep in the intron 5 of GLB1. The patient’s mRNA analysis and the detailed functional analysis revealed the underlying molecular genetic mechanism of pathogenesis, which is an alteration of the GLB1 normal splicing. By co-expression of minigenes and antisense splice-modulating oligonucleotides (ASMOs), we demonstrated that pseudogene-derived splicing regulatory motifs contributed to an activation of the cryptic exon located 36 bp upstream of the integration site. Blocking the cryptic exon with ASMOs incorporated in the modified U7 small nuclear RNA (modU7snRNA) almost completely restored the wild-type splicing in the model cell line, that could be further extended toward the personalized genetic therapy. To our knowledge, this is the second reported case of the processed pseudogene insertion for monogenic disorders. Our data emphasizes the unique role of WGS in identification of such rare and probably underrepresented in literature types of disease-associated genetic variants.https://doi.org/10.1038/s41525-022-00315-y
spellingShingle Igor Bychkov
Antonina Kuznetsova
Galina Baydakova
Leonid Gorobets
Vladimir Kenis
Alena Dimitrieva
Alexandra Filatova
Vyacheslav Tabakov
Mikhail Skoblov
Ekaterina Zakharova
Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape
npj Genomic Medicine
title Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape
title_full Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape
title_fullStr Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape
title_full_unstemmed Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape
title_short Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape
title_sort processed pseudogene insertion in glb1 causes morquio b disease by altering intronic splicing regulatory landscape
url https://doi.org/10.1038/s41525-022-00315-y
work_keys_str_mv AT igorbychkov processedpseudogeneinsertioninglb1causesmorquiobdiseasebyalteringintronicsplicingregulatorylandscape
AT antoninakuznetsova processedpseudogeneinsertioninglb1causesmorquiobdiseasebyalteringintronicsplicingregulatorylandscape
AT galinabaydakova processedpseudogeneinsertioninglb1causesmorquiobdiseasebyalteringintronicsplicingregulatorylandscape
AT leonidgorobets processedpseudogeneinsertioninglb1causesmorquiobdiseasebyalteringintronicsplicingregulatorylandscape
AT vladimirkenis processedpseudogeneinsertioninglb1causesmorquiobdiseasebyalteringintronicsplicingregulatorylandscape
AT alenadimitrieva processedpseudogeneinsertioninglb1causesmorquiobdiseasebyalteringintronicsplicingregulatorylandscape
AT alexandrafilatova processedpseudogeneinsertioninglb1causesmorquiobdiseasebyalteringintronicsplicingregulatorylandscape
AT vyacheslavtabakov processedpseudogeneinsertioninglb1causesmorquiobdiseasebyalteringintronicsplicingregulatorylandscape
AT mikhailskoblov processedpseudogeneinsertioninglb1causesmorquiobdiseasebyalteringintronicsplicingregulatorylandscape
AT ekaterinazakharova processedpseudogeneinsertioninglb1causesmorquiobdiseasebyalteringintronicsplicingregulatorylandscape